Methylphenidate hydrochloride

Methylphenidate hydrochloride is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about methylphenidate hydrochloride automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain methylphenidate hydrochloride, including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - methylphenidate hydrochloride

Audience:
       

(Medicine)
12 Oct 2016 Concerta Extended-Release Tablets is a brand of medicine containing the active ingredient methylphenidate hydrochloride. Find out about side effects, who can take it and who shouldn’t use Concerta Extended-Release Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Medicine)
01 Jun 2015 Ritalin LA Capsules is a brand of medicine containing the active ingredient methylphenidate hydrochloride. Find out about side effects, who can take it and who shouldn’t use Ritalin LA Capsules by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Medicine)
12 Dec 2014 Ritalin Tablets is a brand of medicine containing the active ingredient methylphenidate hydrochloride. Find out about side effects, who can take it and who shouldn’t use Ritalin Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
For health professionals (Health professional publication)
01 Apr 2008 A second controlled-release formulation of methylphenidate (Ritalin LA) was listed on the PBS to be prescribed for patients aged 6 to 18 years inclusive for attention deficit hyperactivity disorder (ADHD).
For health professionals (Health professional publication)
01 Jul 2007 Reviews use of atomoxetine for ADHD in children, adolescents, and adults, and compares atomoxetine with methylphenidate, dexamphetamine, and other psychostimulants.
For health professionals (Health professional publication)
01 Jul 2007 Reviews use of atomoxetine for ADHD in children, adolescents, and adults, and compares atomoxetine with methylphenidate, dexamphetamine, and other psychostimulants.
For health professionals (Health professional publication)
01 Feb 2007 NPS is a member-based organisation providing accurate, balanced, evidence-based information and services to health professionals and the community on Quality Use of Medicines (QUM). To achieve this we work in partnership with GPs, pharmacists, specialists, other health professionals, Government, pharmaceutical industry, consumer organisations and the community. We are independent, non-profit and funded by the Australian Government Department of Health and Ageing.
For health professionals (Health professional publication)
01 Feb 2007 Reviews use of extended-release methylphenidate, including comparison with immediate-release formulation and risk of cardiovascular adverse effects.
For health professionals (Health professional publication)
01 Aug 2005 Reviews use of methylphenidate for attention deficit hyperactivity disorder, including drug control issues and combination with non-drug interventions.

Medicine brands that contain methylphenidate hydrochloride